Literature DB >> 12629098

Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment.

Barbara M Misof1, Paul Roschger, Felicia Cosman, Etah S Kurland, Walter Tesch, Phaedra Messmer, David W Dempster, Jeri Nieves, Elizabeth Shane, Peter Fratzl, Klaus Klaushofer, John Bilezikian, Robert Lindsay.   

Abstract

Anabolic effects of PTH have been observed at several skeletal sites in humans by dual x-ray absorptiometry without differentiating between an actual increase in bone volume and an increase in mineral content within already established bone. The present study addressed this issue by evaluating the bone mineralization density distribution of iliac crest bone biopsies before and after PTH treatment for 18-36 months in men and women with osteoporosis using quantitative backscattered electron imaging. In cortical bone, pairwise comparison of the two biopsies before and after treatment revealed a reduction in the typical calcium concentration in men (-3.32%; P = 0.02, by paired t test), but no change in women, and the heterogeneity of mineralization increased in both males and females [+18.80% (P = 0.09) and +18.14% (P = 0.005), respectively]. In cancellous bone, there was no change in the typical calcium concentration, but there was a greater heterogeneity of mineralization in both men and women [+19.65% (P = 0.02) and +21.59% (P = 0.056), respectively] due to newly formed bone matrix. Small angle x-ray scattering performed on a subgroup of subjects revealed normal collagen/mineral structure. The findings confirm the observations that PTH stimulates skeletal remodeling, resulting in an increased percentage of newly formed bone matrix of lower mineral density.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629098     DOI: 10.1210/jc.2002-021988

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  52 in total

1.  Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.

Authors:  H M Macdonald; K K Nishiyama; D A Hanley; S K Boyd
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.

Authors:  Maria-Grazia Ascenzi; Vivian P Liao; Brittany M Lee; Fabrizio Billi; Hua Zhou; Robert Lindsay; Felicia Cosman; Jeri Nieves; John P Bilezikian; David W Dempster
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

Review 3.  Bone quality: where do we go from here?

Authors:  Mary L Bouxsein
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

4.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

Review 5.  Bone geometry and skeletal fragility.

Authors:  Mary L Bouxsein; David Karasik
Journal:  Curr Osteoporos Rep       Date:  2006-06       Impact factor: 5.096

6.  Influence of remodeling on the mineralization of bone tissue.

Authors:  G Boivin; D Farlay; Y Bala; A Doublier; P J Meunier; P D Delmas
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

7.  Effects of bone anabolic agents on bone ultrastructure.

Authors:  B Cortet
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

Review 8.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 9.  Bone quality: the determinants of bone strength and fragility.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; Hans-Joachim Appell Coriolano; José Alberto Duarte
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

10.  Recent advances toward the clinical application of PTH (1-34) in fracture healing.

Authors:  Cara A Cipriano; Paul S Issack; Lisa Shindle; Clément M L Werner; David L Helfet; Joseph M Lane
Journal:  HSS J       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.